Konstantinos Xynos

Insider Reports History

Location
Woburn, MA
Signature
/s/ Shawn Glidden, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Konstantinos Xynos:

Company Role Class Num Shares Value Price $ Report Date Ownership
Replimune Group, Inc. Chief Medical Officer Common Stock 199,685 $1,823,124 $9.13 19 Dec 2025 Direct
Replimune Group, Inc. Chief Medical Officer Employee Stock Option (right to buy) 67,500 01 Apr 2025 Direct

Insider Reports Filed by Konstantinos Xynos

Symbol Company Period Transactions Value $ Form Type Role Filing Time
REPL Replimune Group, Inc. 19 Dec 2025 1 $0 4 Chief Medical Officer 19 Dec 2025, 17:13
REPL Replimune Group, Inc. 17 Nov 2025 1 -$65,957 4 Chief Medical Officer 19 Nov 2025, 16:30
REPL Replimune Group, Inc. 20 May 2025 1 -$64,093 4 Chief Medical Officer 22 May 2025, 21:46
REPL Replimune Group, Inc. 01 Apr 2025 2 $0 4 Chief Medical Officer 03 Apr 2025, 20:04
REPL Replimune Group, Inc. 18 Nov 2024 1 -$78,112 4 Chief Medical Officer 20 Nov 2024, 21:31
REPL Replimune Group, Inc. 07 Jun 2024 1 -$119,108 4 Chief Medical Officer 10 Jun 2024, 20:30
REPL Replimune Group, Inc. 16 May 2024 1 -$41,194 4 Chief Medical Officer 20 May 2024, 20:00
REPL Replimune Group, Inc. 01 Apr 2024 2 $0 4 Chief Medical Officer 03 Apr 2024, 20:02
REPL Replimune Group, Inc. 16 Nov 2023 1 -$79,858 4 Chief Medical Officer 17 Nov 2023, 20:01
REPL Replimune Group, Inc. 16 May 2023 1 -$13,917 4 Chief Medical Officer 18 May 2023, 20:31
REPL Replimune Group, Inc. 01 Apr 2023 2 $0 4 Chief Medical Officer 04 Apr 2023, 20:02
REPL Replimune Group, Inc. 01 Dec 2022 2 $0 4 Chief Medical Officer 05 Dec 2022, 19:01
REPL Replimune Group, Inc. 01 Dec 2022 0 $0 3 Chief Medical Officer 05 Dec 2022, 19:00